AACR 2026

New York, September 2, 2026 SELLAS Life Sciences Group, Inc. announced that three abstracts evaluating SLS009 (tambiciclib), a potent...

DALLAS, Texas, July 21, 2026 Vesalio has announced that its NATURE randomized clinical trial evaluating the enVast™ Coronary Thrombectomy...

PHILADELPHIA, April 21, 2026 Verismo Therapeutics has unveiled compelling preclinical and early clinical findings for SynKIR™-310, its investigational multi-chain...

ZURICH, Switzerland, July 20, 2026 VERAXA Biotech AG (NASDAQ: VRXA) announced that it has received Scientific Advice from Germany’s...

RALEIGH, North Carolina, USA & TEL AVIV, Israel – June 9, 2026 RedHill Biopharma has received a significant regulatory...

NEW YORK, May 15, 2026 MiNK Therapeutics, Inc. reported first quarter 2026 financial results while highlighting major clinical and...

STRATFORD, Conn., May 8, 2026 KUBTEC Scientific has launched the XCELL® TomoRad™ x-ray irradiator, a next-generation image-guided radiotherapy (IGRT)...

NEW YORK, May 6, 2026 Nuvation Bio Inc., a global oncology-focused biopharmaceutical company, has announced that the U.S. Food...

CAMBRIDGE, UK, April 24, 2026 Amphista Therapeutics has unveiled new preclinical data demonstrating the therapeutic potential of its SMARCA2...

Hong Kong, April 20, 2026 In a significant breakthrough in oncology immunotherapy, Akeso, Inc. has announced promising Phase II...